CA125 serum levels were assessed in 23 patients undergoing chemotherapy for advanced epithelial ovarian carcinoma (EOC). Rising, falling and unchanged levels correlated with disease in 21 out of 23 (95%) cases. Ten out of 11 patients who showed objective response to chemotherapy had a decrease in antigen levels. Two out of 3 patients with stable disease had unchanged values. Progression was always associated with rising levels. CA125 is a reliable marker for monitoring response to chemotherapy in advanced epithelial ovarian carcinoma.
|Number of pages||3|
|Journal||International Journal of Cancer|
|Issue number||SUPPL. 3|
|Publication status||Published - 1988|
ASJC Scopus subject areas
- Cancer Research